甘李药业股份有限公司 股东及董事减持股份结果公告

Group 1 - The major shareholder and board members hold a total of 241,116,992 shares, representing 40.11% of the company's total equity, with Beijing Xute Hongda Technology Co., Ltd. holding 35,473,235 shares (5.90%) and Mr. Gan Zhongru holding 205,643,757 shares (34.21%) [1] - The company announced a share reduction plan on July 5, 2025, where Xute Hongda planned to reduce up to 3,399,518 shares (0.57% of total equity) and board member Jiao Jiao planned to reduce up to 67,500 shares (0.0112% of total equity) [2] - The share reduction plan was successfully completed, with Xute Hongda reducing 3,399,501 shares and Jiao Jiao reducing 67,500 shares within the specified time frame [2]